The Medicines and Healthcare products Regulatory Agency (MHRA) has reminded healthcare professionals to warn patients about common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs). Simultaneously, the House of Lords food, diet, and obesity committee declared a public health emergency on obesity and diet-related diseases and recommended a tax on on junk …
